Abstract
Adding C-reactive protein (CRP) level to conventional cardiovascular risk models has been suggested to improve risk prediction for cardiovascular events. However, evaluation of the potential impact of CRP measurement in cardiovascular risk management will require studies designed to quantify the effect of additional CRP assessment on medical decision-making, patient outcomes, and cost-effectiveness.
Original language | English |
---|---|
Pages (from-to) | 12-14 |
Number of pages | 3 |
Journal | Nature Reviews Cardiology |
Volume | 10 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2013 |
Keywords
- Biomarkers
- C-Reactive Protein
- Cardiovascular Diseases
- Decision Support Techniques
- Humans
- Inflammation Mediators
- Mass Screening
- Predictive Value of Tests
- Prognosis
- Risk Assessment
- Risk Factors
- Journal Article